Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $117
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice TargetHot
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $117.
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $110 to $117.